STRATA Skin Sciences to be Delisted from Nasdaq, Plans to Go Dark

summarizeSummary

STRATA Skin Sciences, Inc. will be delisted from Nasdaq on February 19, 2026, and plans to 'go dark' by terminating its SEC reporting obligations, citing an inability to meet listing requirements and unsuccessful funding efforts.

check_boxKey Events

• Delisting Confirmed

  The company will be delisted from The Nasdaq Capital Market on February 19, 2026, for failing to meet the minimum stockholders' equity requirement.

• No Appeal Intended

  STRATA Skin Sciences, Inc. has decided not to appeal Nasdaq's delisting determination, confirming the impending removal from the exchange.

• Plans to 'Go Dark'

  The company expects to file a Form 15 around March 2, 2026, to terminate its SEC registration and suspend reporting obligations, citing cost savings and increased focus on operations.

• Unsuccessful Funding Efforts

  Despite engaging investment banks and attempting an equity offering, the company could not secure sufficient funding to meet Nasdaq requirements without significant dilution.

auto_awesomeAnalysis

STRATA Skin Sciences, Inc. announced its imminent delisting from The Nasdaq Capital Market due to its failure to meet the minimum stockholders' equity requirement. Despite efforts to secure funding, the company was unable to raise sufficient capital without incurring significant dilution. The company has decided not to appeal Nasdaq's determination, leading to a trading suspension on February 19, 2026. Furthermore, the company intends to 'go dark' by deregistering its common stock and suspending its reporting obligations, which will severely impact shareholder liquidity and transparency. This development, occurring while the stock trades near its 52-week low, signals a critical deterioration in the company's public market viability.